Medmix AG (CHIX:MEDXZ) EPS (Basic): CHF0.00 (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:MEDXZ Medmix AG CHIX:MEDXZ
66 GF Score
Price CHF8.54
GF Value CHF9.05
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Medmix AG EPS (Basic)?

Medmix AG CHIX:MEDXZ +1.97% 66 EPS (Basic) is CHF0.00 as of Jun. 2026. GuruFocus rates CHIX:MEDXZ with a GF Score™ of 66/100 and a GF Value™ of CHF9.05 (Fairly Valued). The stock has 6 warning signs investors should review.

Medmix AG's basic earnings per share (Basic EPS) for the six months ended in Jun. 2026 was CHF0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2026 was CHF0.00.

Medmix AG's EPS (Diluted) for the six months ended in Jun. 2026 was CHF0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was CHF0.00.

Medmix AG's EPS without NRI for the six months ended in Jun. 2026 was CHF0.14. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2026 was 0.27.

During the past 3 years, the average EPS without NRI Growth Rate was -41.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Medmix AG's highest 3-Year average EPS without NRI Growth Rate was -2.90% per year. The lowest was -57.60% per year. And the median was -24.80% per year.

Medmix AG  (CHIX:MEDXz) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Medmix AG EPS (Basic) Related Terms

Medmix AG EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Medmix AG's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medmix AG EPS (Basic) Chart

Medmix AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial 1.07 0.28 0.01 -0.18 0.16

Medmix AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 -0.31 0.17 -0.01 0.01
CHIX:MEDXZ
66GF Score
Medmix AG CHIX:MEDXZ
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medmix AG EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Medmix AG's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(6.4-0)/40.774
=0.16

Medmix AG's Basic EPS for the quarter that ended in Jun. 2026 is calculated as

Basic EPS (Q: Jun. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0.5-0)/50.000
=0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of CHF0.00 mean?
Medmix AG (CHIX:MEDXZ) has a EPS (Basic) of CHF0.00 as of Jun. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Medmix AG and its competitors.
Is Medmix AG's EPS (Basic) too high?
Medmix AG's current EPS (Basic) is CHF0.00. Overall, Medmix AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's EPS (Basic) compare to GEV and ETN?
Medmix AG's EPS (Basic) of CHF0.00 can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for an Industrial Products company?
A good EPS (Basic) depends on the Industrial Products industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Medmix AG and its competitors. Medmix AG's current EPS (Basic) is CHF0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.05, compared to a current price of CHF8.54 — trading 5.7% below its estimated fair value. The current EPS (Basic) is CHF0.00. Medmix AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current EPS (Basic) is CHF0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?

Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued. The current stock price of CHF8.54 is trading 5.7% below its estimated GF Value™ of CHF9.05. GuruFocus considers Medmix AG to be Fairly Valued.

Key valuation signals for CHIX:MEDXZ:

  • EPS (Basic): CHF0.00
  • GF Value™: CHF9.05 vs. price of CHF8.54 (5.7% below fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medmix AG Business Description

Other Exchanges MEDX:Switzerland
Address Neuhofstrasse 20, Baar, CHE, 6340
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
66GF Score

Get the complete analysis for CHIX:MEDXZ

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF8.54
Price
CHF9.05
GF Value